SCHEMBL2710669

SCHEMBL2710669

Nc1cccc(-c2ccn(-c3cccc(C(=O)O)c3)n2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
FYN P06241 1/20 0.44
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 4/20 0.43
GAA P10253 3/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
MAPT P10636 3/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
KMO O15229 2/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL182136 0.92 KEAP1 (0.51) KEAP1NFE2L2MAOAMAOBMEN1
SCHEMBL181817 0.88 ALDH1A1 (0.49) KEAP1NFE2L2MAOAMAOBMEN1
SCHEMBL27824806 0.87 KMO (0.59) KEAP1NFE2L2MAOAMAOBMEN1
SCHEMBL182162 0.86 KMO (0.53) KEAP1NFE2L2KDM4EALDH1A1NPC1
SCHEMBL2710273 0.85 KMO (0.49) KEAP1NFE2L2MAOAMAOBMEN1
SCHEMBL5199932 0.85 MEN1 (0.54) KEAP1NFE2L2MEN1KMT2AKDM4E
SCHEMBL181774 0.85 GRM5 (0.47) KEAP1NFE2L2MAOAMAOBFYN
SCHEMBL182177 0.84 CA2 (0.50) KEAP1NFE2L2FYNMEN1KMT2A
SCHEMBL2707490 0.84 POLB (0.57) KEAP1NFE2L2MEN1KMT2AKDM4E
SCHEMBL2708555 0.83 ALDH1A1 (0.50) MAOAMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387995-A1 Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith PTC Therapeutics, Inc. (US) 2011-11-23 EP disclosed
WO-2007117438-A2 METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCIATED THEREWITH PTC THERAPEUTICS, INC. (US) 2007-10-18 WO disclosed